HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

‘General Benefit’ Insufficient For EU Food For Special Medical Purposes Classification

Executive Summary

In a case that could have far-reaching implications for the region's food supplement manufacturers, the European Court of Justice has ruled that the definition of foods for special medical purposes should be restricted to use in addressing a specific nutrient deficiency related to an illness, as defined by EU law.

You may also be interested in...



Instagram Now Social Network Of Choice For Spain’s OTC Firms As Market Grows Double-Digits

Instagram is now the most important social network for Spanish OTC companies, according to the results of a recent survey by the country’s self-care industry association, ANEFP. Meanwhile, ANEFP predicts 11% growth in the country's self-care market by the end of 2022.

‘Little To No Evidence’ To Support D-Mannose Supplementation For UTIs – Cochrane Review

Evidence for or against supplementation with D-mannose, a monosaccharide naturally found in fruits like cranberries, to prevent or treat acute or recurrent urinary tract infections is found wanting by a scientific review recently published in the Cochrane Library. 

Almost All Top German OTC Companies Have Now Raised Prices Due To Inflation – Sempora

87 of the top 100 German OTC manufacturers are now reporting inflation-driven price increases, up from 72 at the same point last year. Sempora Consulting suggests a number of strategies to address the current economic challenges companies face. 

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS153129

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel